VAXART INC (VXRT) Stock Price, Quote, News and Overview
NASDAQ:VXRT - Nasdaq - US92243A2006 - Common Stock - Currency: USD
VXRT Quote, Performance and Key Statistics
0.7135
+0.01 (+1.21%)
The current stock price of VXRT is 0.7135 USD. In the past month the price decreased by -7.3%. In the past year, price decreased by -43.82%.
VXRT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About VXRT
Company Profile
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. The company is headquartered in South San Francisco, California and currently employs 109 full-time employees. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its development programs include pill vaccines designed to protect against norovirus (cause for acute gastroenteritis), coronavirus, including SARS-CoV-2 (COVID-19)), and influenza. In addition, it has generated preclinical data for its therapeutic vaccine candidate targeting cervical cancer and dysplasia caused by human papillomavirus. The firm's platform technology employs a vector-based approach and consists of various components, such as a vector (adenovirus type 5 (Ad5); an antigen (Ad5 DNA); an adjuvant (Toll-like receptor 3 (TLR3)), and its proprietary enteric-coated tablet.
Company Info
VAXART INC
170 Harbor Way, Suite 300
South San Francisco CALIFORNIA 94080 US
CEO: Andrei Floroiu
Employees: 109
Company Website: https://vaxart.com/
Investor Relations: https://investors.vaxart.com/
Phone: 16505503500
VAXART INC / VXRT FAQ
What is the stock price of VAXART INC today?
The current stock price of VXRT is 0.7135 USD. The price increased by 1.21% in the last trading session.
What is the ticker symbol for VAXART INC stock?
The exchange symbol of VAXART INC is VXRT and it is listed on the Nasdaq exchange.
On which exchange is VXRT stock listed?
VXRT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VAXART INC stock?
9 analysts have analysed VXRT and the average price target is 4.93 USD. This implies a price increase of 590.96% is expected in the next year compared to the current price of 0.7135. Check the VAXART INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VAXART INC worth?
VAXART INC (VXRT) has a market capitalization of 162.31M USD. This makes VXRT a Micro Cap stock.
How many employees does VAXART INC have?
VAXART INC (VXRT) currently has 109 employees.
What are the support and resistance levels for VAXART INC (VXRT) stock?
VAXART INC (VXRT) has a support level at 0.71 and a resistance level at 0.72. Check the full technical report for a detailed analysis of VXRT support and resistance levels.
Is VAXART INC (VXRT) expected to grow?
The Revenue of VAXART INC (VXRT) is expected to grow by 433.87% in the next year. Check the estimates tab for more information on the VXRT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy VAXART INC (VXRT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VXRT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VXRT, evaluating the profitability, health, valuation and growth aspects
- VAXART INC (VXRT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VAXART INC (VXRT) Sales and EPS estimates to see what analysts future expectations are.
- VAXART INC (VXRT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VAXART INC (VXRT) Insider and Institutional Ownership to learn about the owners and their transactions.
- VAXART INC (VXRT) Stock Chart to make your own analysis
- VAXART INC (VXRT) Latest news and press-releases to stay up to date.
Does VAXART INC (VXRT) stock pay dividends?
VXRT does not pay a dividend.
When does VAXART INC (VXRT) report earnings?
VAXART INC (VXRT) will report earnings on 2025-05-12.
What is the Price/Earnings (PE) ratio of VAXART INC (VXRT)?
VAXART INC (VXRT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.41).
What is the Short Interest ratio of VAXART INC (VXRT) stock?
The outstanding short interest for VAXART INC (VXRT) is 4.93% of its float. Check the ownership tab for more information on the VXRT short interest.
VXRT Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to VXRT. When comparing the yearly performance of all stocks, VXRT is a bad performer in the overall market: 79.31% of all stocks are doing better.
VXRT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VXRT. VXRT has a bad profitability rating. Also its financial health evaluation is rather negative.
VXRT Financial Highlights
Over the last trailing twelve months VXRT reported a non-GAAP Earnings per Share(EPS) of -0.41. The EPS increased by 35.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -43.4% | ||
| ROE | -105.69% | ||
| Debt/Equity | 0.03 |
VXRT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 87% to VXRT. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 32% and a revenue growth 433.87% for VXRT